Bull
$3.34
Scenario price
$0.155
+0.065 (+41.98%)At close
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Baird Medical Partners with Alpmed to Advance IRE System

Baird Medical to Present at H.C. Wainwright Conference

Baird Medical Secures Product Registrations in Pakistan

Baird Medical and Alpmed Forge Strategic Partnership for IRE Technology

Baird Medical Partners with Alpmed for IRE Technology Development
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market. It operates in the Healthcare sector.
Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.